Health in North Korea

971 indicators covering health for North Korea.

IndicatorLatest Year10-yr change Rank
Estimated malaria incidence 0.5052 2024 down 52.3% 66th
Estimated malaria mortality rate 0 2024 66th
Number of new G2D leprosy cases 0 2024 86th
Leprosy - New leprosy cases with G2D rate per 1 000 000 population 0 2024 86th
3.7.2 Adolescent birth rate per 1,000 women 1 2017 184th
Taxes as a % of price: total tax 0.0% 2022 189th
Taxes as a % of price: value added tax 0.0% 2022 177th
Taxes as a % of price: ad valorem excise 0.0% 2022 106th
Taxes as a % of price: specific excise 0.0% 2022 135th
Taxes as a % of price: import duties 0.0% 2022 38th
Taxes as a % of price: other taxes 0.0% 2022 57th
Vitamin A supplementation coverage rate 77.0% 2023 down 21.4% 23rd
Physical activity policies for activie societies 10 2023 unchanged 113th
Physical activity policies focused on active systems 20 2023 up 100.0% 5th
Midwifery personnel 4,277 2024 down 46.6% 49th
Number of deaths from malaria 0 Deaths 2024 66th
Death rate from malaria 0 Deaths 2024 66th
New cases of malaria per 1,000 people at risk 0.51 per 1,000 population at risk 2024 down 51.9% 65th
Death rate from unintentional poisoning 1.3 per 100,000 population 2021 down 7.1% 33rd
3.8.1 Coverage of essential health services 68 2021 up 28.3% 99th
Prevalence of stunting, height for age 19.1% 2017 down 41.0% 47th
Japanese encephalitis - number of reported cases 0 2022 19th
Malaria cases reported 5,233 2024 down 50.3% 62nd
Mean systolic blood pressure 123.2 2009 up 1.7% 127th
Mean fasting blood glucose (mmol/l) 5.1 2009 unchanged 146th
Number of new leprosy cases with G2D among children 0 2024 35th
Neonates protected at birth against neonatal tetanus (PAB) 98.0% 2022 up 5.4% 15th
Most sold brand of cigarettes - price in currency reported 229 2020 up 1,045.0% 61st
Most sold brand of cigarettes - price in US$ at official exchange 2.14 2020 up 1,428.6% 113th
Number of non-autochthonous leprosy cases 0 2024 47th
Tuberculosis - new and relapse cases 91,433 2011 up 212.2% 14th
Diarrhea treatment 74.1% 2017 up 0.1% 5th
Average of 13 International Health Regulations core capacity scores 66.82 2017 up 13.3% 104th
New cases: pulmonary smear-negative 35,959 2012 up 108.8% 10th
Number of full-time equivalent staff in national agency 8 2022 unchanged 35th
Total number of notified TB cases 110,290 2014 up 111.0% 12th
New cases: pulmonary smear unknown/not done 0 2009 down 100.0% 109th
Smear-positive tuberculosis treatment-success rate 90.0% 2011 unchanged 30th
Number of presumed malaria cases 0 2024 down 100.0% 40th
Number of indigenous malaria cases 5,233 2024 down 25.5% 62nd
Number of confirmed malaria cases 5,233 2024 down 25.5% 64th
Total number of  malaria cases 5,233 2024 down 29.4% 64th
Retreatment cases: treatment after default 1,679 2012 down 11.1% 5th
Number of indigenous P. falciparum malaria cases 0 2023 75th
Number of suspected malaria cases 28,113 2024 down 69.1% 88th
Retreatment cases: other 3,481 2012 down 8.3% 14th
Retreatment cases: treatment after failure 2,354 2012 up 726.0% 4th
Number of malaria positive cases by microscopy 5,233 2024 down 25.3% 55th
Unmet need for contraception 6.6% 2017 down 58.2% 57th
Number of malaria suspects examined by microscopy 28,113 2024 down 4.0% 75th
Absolute number of deaths from ambient particulate air pollution 18,800 Percent 2015 up 24.5% 29th
Expected funding for tuberculosis versus required budget 6.03 million constant 2022 US$ 2022 35th
Height-for-age <-2 SD 19.1 2017 down 41.0% 47th
Weight-for-age <-2 SD 9.3 2017 down 50.5% 53rd
Domestic Expenditure on Malaria 0 2024 down 100.0% 75th
Laboratories providing tuberculosis diagnostic services using culture 0.2 2014 down 66.7% 137th
Number of malaria positive cases by rapid diagnostic test 0 2024 down 100.0% 83rd
Laboratories providing tuberculosis diagnostic services using sputum 1.4 2014 up 27.3% 60th
Vitamin A Supplementation, Semester 2 Coverage 77 2023 down 21.4% 29th
Vitamin A Supplementation, Semester 1 Coverage 99 2023 up 1.0% 1st